Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Electronic applications for the CFQ-R scoring

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{f42148128e8f4726a20aa0afdb15b4db,
title = "Electronic applications for the CFQ-R scoring",
abstract = "Patient reported outcomes (PROs) have become widely accepted outcome measures in cystic fibrosis (CF) and other respiratory diseases. The Cystic Fibrosis-Questionnaire-Revised (CFQ-R) is the best validated and most widely used PRO for CF. Data collection can be time-intensive, and electronic platforms would greatly facilitate the feasibility, utility and accuracy of administration of the CFQ-R. Given that the CFQ-R is utilized in virtually all clinical trials worldwide and is increasingly integrated into clinical practice, we developed a software application that will help users to administer, score and save CFQ-R data for all versions. All codes are open access, which will enable other PRO users to design similar applications for other respiratory diseases, such as primary ciliary dyskinesia and non-CF bronchiectasis.",
keywords = "Letter",
author = "Andreas Ronit and Marco Gelpi and Jonathan Argentiero and Inger Mathiesen and Nielsen, {Susanne D} and Tanja Pressler and Quittner, {Alexandra L}",
year = "2017",
month = "5",
day = "30",
doi = "10.1186/s12931-017-0592-z",
language = "English",
volume = "18",
pages = "e108",
journal = "Respiratory Research",
issn = "1465-9921",
publisher = "BioMed Central Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - Electronic applications for the CFQ-R scoring

AU - Ronit, Andreas

AU - Gelpi, Marco

AU - Argentiero, Jonathan

AU - Mathiesen, Inger

AU - Nielsen, Susanne D

AU - Pressler, Tanja

AU - Quittner, Alexandra L

PY - 2017/5/30

Y1 - 2017/5/30

N2 - Patient reported outcomes (PROs) have become widely accepted outcome measures in cystic fibrosis (CF) and other respiratory diseases. The Cystic Fibrosis-Questionnaire-Revised (CFQ-R) is the best validated and most widely used PRO for CF. Data collection can be time-intensive, and electronic platforms would greatly facilitate the feasibility, utility and accuracy of administration of the CFQ-R. Given that the CFQ-R is utilized in virtually all clinical trials worldwide and is increasingly integrated into clinical practice, we developed a software application that will help users to administer, score and save CFQ-R data for all versions. All codes are open access, which will enable other PRO users to design similar applications for other respiratory diseases, such as primary ciliary dyskinesia and non-CF bronchiectasis.

AB - Patient reported outcomes (PROs) have become widely accepted outcome measures in cystic fibrosis (CF) and other respiratory diseases. The Cystic Fibrosis-Questionnaire-Revised (CFQ-R) is the best validated and most widely used PRO for CF. Data collection can be time-intensive, and electronic platforms would greatly facilitate the feasibility, utility and accuracy of administration of the CFQ-R. Given that the CFQ-R is utilized in virtually all clinical trials worldwide and is increasingly integrated into clinical practice, we developed a software application that will help users to administer, score and save CFQ-R data for all versions. All codes are open access, which will enable other PRO users to design similar applications for other respiratory diseases, such as primary ciliary dyskinesia and non-CF bronchiectasis.

KW - Letter

U2 - 10.1186/s12931-017-0592-z

DO - 10.1186/s12931-017-0592-z

M3 - Journal article

VL - 18

SP - e108

JO - Respiratory Research

JF - Respiratory Research

SN - 1465-9921

IS - 1

ER -

ID: 52170080